Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Higher-dose Transdermal Estradiol in Premature Ovarian Insufficiency
NCT05737329Phase 2Unknown
- Start
- Mar 2019
- Primary completion
- Apr 2023
- Countries
- 1
01
Overview
Phase 2, open-label trial of estradiol topical in primary ovarian insufficiency (POI). Primary endpoint: Severity of estrogen deficiency symptoms at 3 months. Status: unknown.
02
Drugs
estradiol topical
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT05737329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05737329.